DE60030884D1 - Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten - Google Patents

Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten

Info

Publication number
DE60030884D1
DE60030884D1 DE60030884T DE60030884T DE60030884D1 DE 60030884 D1 DE60030884 D1 DE 60030884D1 DE 60030884 T DE60030884 T DE 60030884T DE 60030884 T DE60030884 T DE 60030884T DE 60030884 D1 DE60030884 D1 DE 60030884D1
Authority
DE
Germany
Prior art keywords
dna binding
transcription factors
potential dna
factors containing
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60030884T
Other languages
English (en)
Other versions
DE60030884T2 (de
Inventor
Hilary Banham
Loelia Cordell
Margaret Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9928543.9A external-priority patent/GB9928543D0/en
Priority claimed from GB0017042A external-priority patent/GB0017042D0/en
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Application granted granted Critical
Publication of DE60030884D1 publication Critical patent/DE60030884D1/de
Publication of DE60030884T2 publication Critical patent/DE60030884T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60030884T 1999-12-02 2000-12-01 Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten Expired - Fee Related DE60030884T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9928543.9A GB9928543D0 (en) 1999-12-02 1999-12-02 Novel transcription factors
GB9928543 1999-12-02
GB0017042 2000-07-11
GB0017042A GB0017042D0 (en) 2000-07-11 2000-07-11 Novel transcription factors
PCT/GB2000/004590 WO2001040303A1 (en) 1999-12-02 2000-12-01 Transcription factors containing two potential dna binding motifs

Publications (2)

Publication Number Publication Date
DE60030884D1 true DE60030884D1 (de) 2006-11-02
DE60030884T2 DE60030884T2 (de) 2007-04-26

Family

ID=26244636

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60030884T Expired - Fee Related DE60030884T2 (de) 1999-12-02 2000-12-01 Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten

Country Status (9)

Country Link
US (1) US20030139330A1 (de)
EP (1) EP1246841B1 (de)
JP (1) JP2003515328A (de)
AT (1) ATE340188T1 (de)
AU (1) AU1539801A (de)
CA (1) CA2394996A1 (de)
DE (1) DE60030884T2 (de)
ES (1) ES2272336T3 (de)
WO (1) WO2001040303A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003100422A1 (fr) * 2002-05-28 2003-12-04 Japan Genome Solutions, Inc. Procede de traitement de donnees de microreseau d'adn, systeme de traitement de donnees de microreseau d'adn, processeur de donnees de microreseau d'adn, programme et support d'enregistrement associes
WO2005095447A2 (en) * 2004-03-29 2005-10-13 Isis Innovation Limited Low molecular weight forms of foxp1 proteins and splice variants thereof
DK1786908T3 (da) * 2004-08-18 2010-06-07 Bayer Cropscience Ag Planter med forøget plastidisk aktivitet af stivelsesphosphorylerende R3-enzym
CA2752947A1 (en) * 2011-06-30 2012-12-30 Benjamin J. Blencowe Foxp1 splice variants and methods and uses thereof
WO2013063019A1 (en) * 2011-10-28 2013-05-02 The Wistar Institute Of Anatomy And Biology Methods and compositions for enhancing the therapeutic effect of anti-tumor t cells
US10842565B2 (en) 2016-02-22 2020-11-24 The General Hospital Corporation Systems and methods for selective targeting of structural features in treating skin conditions
EP4217074A1 (de) * 2020-09-28 2023-08-02 The Research Institute at Nationwide Children's Hospital Identifizierung von pax3-foxo1-bindenden genomregionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor

Also Published As

Publication number Publication date
ATE340188T1 (de) 2006-10-15
DE60030884T2 (de) 2007-04-26
CA2394996A1 (en) 2001-06-07
ES2272336T3 (es) 2007-05-01
AU1539801A (en) 2001-06-12
WO2001040303A1 (en) 2001-06-07
EP1246841B1 (de) 2006-09-20
EP1246841A1 (de) 2002-10-09
US20030139330A1 (en) 2003-07-24
JP2003515328A (ja) 2003-05-07

Similar Documents

Publication Publication Date Title
FI961886A (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
EP0770129A4 (de) Derivate von zinkfingerproteinen und methoden
ATE415480T1 (de) B7l-1 moleküle
DE69013520T2 (de) Stabile integration von dna in bakterielle genome.
ATE354675T1 (de) Dna-protein fusionen sowie anwendungen derselben
ATE484587T1 (de) Ldcam genannte moleküle
TR200100074T2 (tr) Nevrotrofik büyüme faktörü
DE69018117T2 (de) Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
WO1994012637A3 (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
DE60030884D1 (de) Transkriptionsfaktoren welche zwei potentielle dna bindende motive enthalten
MX9703364A (es) Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso.
DE69739346D1 (de) Gereinigtes sr-p70 protein
ATE340257T1 (de) Histonedeacetylase 9
NZ334359A (en) Regulatory gene sequences and transcription factors that silence and enhance the CD95 gene and its use as a medicament
AU5178698A (en) Novel serine protease inhibitor nucleic acid molecules, proteins and uses hereof
EP0846165A4 (de) Neue cystein-protease von filariiden nematoden, nuklöeinsäuremoleküle und ihre verwendungen
Jones The terminology of guanidine formation
WO2003062447A3 (en) Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
PT778347E (pt) Proteina ligante a atp e acidos nucleicos com propriedade de helicase e de atpase
AU6519999A (en) Isolated proteins and nucleic acid molecules having homology to the nip2 proteinand uses thereof
KR960010861A (ko) 사람 전사 인자 iiia 유전자
CA2284100A1 (en) New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
BR0106125A (pt) Aperfeiçoamento em cadernos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee